Hepatobiliary Surgery and Nutrition

Article	Citations
Reply to: The letter to the editor “More details are needed about the use of multicenter propensity score matching analysis” by Feng et al.	138
Neoadjuvant therapy for resectable pancreatic cancers	80
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?	80
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma	64
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations	61
Acute coil migration in upper gastrointestinal bleeding	46
Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations	42
The limits of segmental dichotomy: rethinking how we classify and compare minimally invasive liver resections	41
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology	40
Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases	40
Does a patient who needs portal vein embolization (PVE) to proceed to major hepatectomy (MH) have the same hepatic functional reserve than a patient with no preoperative PVE?	34
Evidence-based strategies of exercise and nutrition in sarcopenia care in liver cirrhosis patients	32
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study	29
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice	27
Impact of expert centers annual case volume on outcomes of minimally-invasive liver resections: international multicenter study	27
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers	25
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy	23
Therapeutic advances in hepatocellular carcinoma with portal vein tumor thrombus in the era of immuno-targeted therapy—a narrative review	23
Single-port robotic pancreaticoduodenectomy with the SHURUI snake-arm system: first clinical application	22
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience	21
Preoperative assessment of liver function and perioperative management of posthepatectomy liver failure	20
A 7-year-old girl with giant congenital biliary dilatation	19
Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”	18
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular	18
Addressing the malnutrition gap requires high-quality research, recognition of intervention complexity, and equitable implementation strategies	17

Construction and application of multicellular tumor microenvironment models based on three-dimensional bioprinting technology	16
A proposal to simplify the definition of metabolic dysfunction-associated steatotic liver disease in youths	16
Rethinking resectability: the case for neoadjuvant treatment in resectable pancreatic cancer	16
Convergent bioprinting and microfluidics: toward next-generation biomimetic tumor models	16
Evolocumab induced short-term biliary stent blockage and acute cholangitis in a jaundice patient with pancreatic carcinoma: a rare complication of PCSK9 inhibitor	16
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma	15
Innovations in liver organoids: the role of 3D bioprinting in creating functional organoids	14
Expert consensus on difficult airway assessment	14
Propensity score matching study of 325 patients with spontaneous rupture of hepatocellular carcinoma	14
Outcomes after surgery for locally advanced pancreatic cancer compared to borderline and upfront resectable pancreatic cancer	14
The role of resection margin status on recurrence and selection of patients for adjuvant radiotherapy in distal cholangiocarcinoma	14
Performance of major liver resection for gallbladder cancer—a western retrospective single center cohort study	14
Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China	14
Hepatocellular carcinoma surveillance—is it time to update clinical practice?	14
Adjuvant chemoimmunotherapy vs. capecitabine vs. observation in resected biliary tract cancer: a multi-center retrospective study	13
Dietitians’ role in obesity care: insights from the Academy of Nutrition and Dietetics	13
Guidelines for the management of pancreatic cystic lesions: many options, too few solutions?	13
Enhancing diagnostic strategies for biliary strictures: an evolving landscape	12
Robotic hepatectomy: challenge and progression	12
Perioperative management of patients with liver cancer complicated with sarcopenia	11
“One-day, one-stay, and one-step” lessons from the Danish guidelines for the treatment of gallstone disease	11
Highlights of constructing liver-relevant in vitro models with 3D bioprinting	11
How to improve the care of decompensated cirrhosis: the intervention model for chronic disease management	11
Novel biomarkers for hepatocellular carcinoma detection and treatment	11
Does preoperative routine statin use reduce post-hepatectomy liver failure?—an international multicentre retrospective cohort study on 2,342 patients	11
Understanding drug-induced liver injury from the perspective of traditional Chinese medicine theory—Huohou theory of traditional Chinese medicine	10
Clinical outcomes of hepatectomy after partial response to immune checkpoint inhibitor-based combination therapy in patients with extrahepatic hepatocellular carcinoma metastasis	10
The ESSENCE of hope: what semaglutide’s Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis	10
Impact of donor-recipient sex-matching patterns on liver transplantation outcomes: a cohort study based on United Network of Organ Sharing data	10
Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air	10
Should all patients be offered liver venous deprivation for insufficient future liver remnant hypertrophy prior to major hepatectomy?	10
Trimming the fat myth: adipose tissue’s role in liver regeneration	10
Laparoscopic partial splenectomy in the treatment of splenic ectopic pregnancy	9
Resection and yttrium-90 radioembolization as sequential downstaging to living donor liver transplantation for large, multifocal hepatocellular carcinoma with lobar portal vein tumor thrombosis	9
Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions	9
Association of a novel glycemic control index, time in range, with infectious complications after pancreatectomy	9
Thermal ablation in the curative treatment of colorectal liver metastasis: new standard of care?—lessons learned from the COLLISION trial	9
Deceased donor liver transplant outcomes: does donor drinking matter?	9
Minimally invasive hepatectomy is here to stay, but more evidence is needed	9
Body fat distribution: a crucial target for intervention in nonalcoholic fatty liver disease and fibrosis	9
Construction of an intrahepatic portosystemic shunt using the magnetic compression technique: preliminary experiments in a canine model	9
Refining prognostication in intermediate-stage hepatocellular carcinoma after transarterial chemoembolization: promise and limitations of the proposed NTAA model	9
Difficulties and opportunities of hospice care—the role of doctors	9
Targeted therapies in cholangiocarcinoma: light at the end of the tunnel?	8
Confounders in developing a machine learning model for colorectal liver metastasis post-hepatectomy prognostications	8
Application progress of spatial omics in hepatobiliary tumor research	8
Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future	8
Liver transplantation for perihilar cholangiocarcinoma is not a provocative idea	8
Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter	8
“Winning” with laparoscopic liver resection for colorectal cancer liver metastases (CRLM)	8

ALPPS versus portal vein embolization for hepatitis B virus-associated hepatocellular carcinoma: a delicate balance between volume and morbidity	8
Validation of the Institute Mutualiste Montsouris system for the stratification of laparoscopic liver resections: an international multicenter study	8
Engineering the tumor microenvironment via 3D multicellular bioprinting for personalized immunotherapy assessment and resistance deciphering	8
Survival after resection of pancreatic cancer is similar with neoadjuvant gemcitabine-nab-paclitaxel or mFOLFIRINOX but one size will not fit all in the future	8
Never change a winning team—liver stiffness measurement and platelet count as key surrogates for clinically significant portal hypertension	8
Development of scoring models to predict early pancreatic cancer risk in new-onset diabetes mellitus patients	8
Robotic-assisted hepatopancreatoduodenectomy and resection of pancreatic tail for one multiple endocrine neoplasia type 1 secreting multiple hormones	8
De-escalating local therapies without compromising outcomes: lessons from the COLLISION trial	8
De-escalating surgical treatment in low stage gallbladder cancer	7
Pushing to resect colorectal liver metastases: rethinking surgical strategy in colorectal liver metastases with extrahepatic spread	7
Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives	7
Novel preoperative strategies to improve hepatocellular carcinoma resectability	7
Algorithm-based care for early recognition and management of complications after pancreatic resection: toward standardization of postoperative care	7
Getting persuasive about the non-invasive: assessing liver fibrosis in practice—without a biopsy	7
Prioritising preventive approaches for metabolic dysfunction-associated steatohepatitis in high-risk populations: a narrative review	7
Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial	7
To drain or not to drain after distal pancreatectomy: reflexions on the PANDORINA trial	7
Surgical resection for pancreatic ductal adenocarcinoma with liver metastasis: is this the beginning of a new era?	7
Feasibility and outcomes of robotic partial pancreatoduodenectomy	7
Alcohol-related liver disease	7
Screening for pancreatic cancer in individuals with genetic susceptibility	7
Eggplant-like pancreas: transformation in a year	6
Acute cholecystitis in older adults with multimorbidity: does surgery offer better outcomes?	6
Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma	6
Advancements and challenges in robotic donor hepatectomy: current evidence and unresolved questions	6
Comparative effectiveness of medical treatment vs. metabolic surgery for histologically proven non-alcoholic steatohepatitis and fibrosis: a matched network meta-analysis	6
Non-invasive strategies to predict post-hepatectomy liver failure	6
Ethical issues in innovative clinical research	6
Ectopic hepatocellular carcinoma of the abdominal wall	6
Frailty assessed using the Liver Frailty IndexTM (LFI) is a risk factor for mortality in patients with advanced hepatocellular carcinoma treated with atezolizumab-bevacizumab	6
Laparoscopic duodenum-preserving pancreatic head resection guided by the two-stage indocyanine green fluorescence imaging	6
Early bifurcation of hepatic artery in right-sided living-donor hepatectomy at Asan Medical Center: rarely a critical issue	6
Necessity of integrating statistical inference and clinical practice in developing clinical models: bias introduced by neoadjuvant chemotherapy	6
The role of FGFR inhibitors in the treatment of intrahepatic cholangiocarcinoma—unveiling the future challenges in drug therapy	6
Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention	6
Evolution of systemic therapy for advanced-stage hepatocellular carcinoma	6
A puzzling mixed cystic-solid mass at the hepatic hilum	6
ESMO 2023 pancreatic cancer guidelines signal stepwise progress	6
Risk predictors of post-hepatectomy liver failure: unraveling complexities and navigating challenges in clinical application	6
A systematic review of methodology in nutritional trials in patients undergoing pancreatoduodenectomy	6
Validation of the European Association for the Study of the Liver algorithm for the noninvasive diagnosis of advanced fibrosis in metabolic-dysfunction associated steatotic liver disease	6
The lymphatic vessels of the liver observed by Frederik Ruysch	6
Nutritional management guidelines for pancreatitis—a commentary	6
Liver transplantation for non-resectable colorectal metastases—an evolving paradigm in transplant oncology	5
In situ liver resection under venovenous bypass (LR-VVB) or venoarterial bypass (LR-VAB) adjunct to total vascular exclusion (TVE) as extreme liver surgery	5
Decision-making in high-risk leakage duodenopancreatectomy: pancreatic anastomosis or total pancreatectomy?	5
Advanced pancreatic neuroendocrine neoplasia (pNEN): complex diseases with therapeutic challenges	5
The Hong Kong consensus recommendations on the diagnosis and management of pancreatic cystic lesions	5
How to deliver palliative care for patients with management in decompensated cirrhosis	5
Can liver stiffness measurement accurately predict disease progression and clinical outcome in patients with metabolic dysfunction-associated steatotic liver disease and bridging fibrosis or cirrhosis	5
Surgical resection for hepatocellular carcinoma in cirrhotic patients with clinically significant portal hypertension: a multidisciplinary team decision	5
How will the latest modifications to the CG189 NICE guidelines for obesity management likely impact clinical care?	5
EREG-secreting THBS1+ tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure	5
Molecular profiling and patient selection for the multimodal approaches for patients with resectable colorectal liver metastases	5
Hepatic “pregnancy”: hepatocellular carcinoma with extensive extrahepatic growth	5
A new TNM T3 subclassification with corresponding prognostic stage grouping for gallbladder cancer: a multicenter retrospective study	5
Rethinking portal hypertension in hepatocellular carcinoma resection: a gradient of risk beyond black and white	5
Can artificial intelligence deliver on the promise of precision medicine?	5
Comparative analysis of analgesic efficacy and functional recovery in open pancreaticoduodenectomy: a randomized controlled trial of local anesthetic wound infiltration, transversus abdominis plane bl	5
Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation	5
Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer	5
Assessment of morbidity and mortality after liver transplantation for primary sclerosing cholangitis	4
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma	4
D’Agoty’s early anatomical painting of the liver	4
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review	4
Sex and age differences in the association between obesity and long-term changes with the risk of incident type 2 diabetes mellitus: the Rural Deqing Cohort Study	4
The global burden of fatty liver disease: the major impact of China	4
Ascites and complications: getting to the root of the trouble	4
Beyond precision: why time and human judgment still matter in the era of autonomous surgery	4
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma	4
Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer	4
An intriguing case of macrolides-induced pancreatic injury mimicking pancreatic carcinoma	4
Is liver resection necessary for T2 gallbladder cancer?	4
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option	4
Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer	4
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach	4
Textbook outcome after robotic vs. laparoscopic hepatectomy: a secondary post-hoc analysis of the randomized ROC‘N’ROLL trial	4
Associations between metabolic dysfunction-associated steatotic liver disease and adverse clinical outcomes in chronic kidney disease: a prospective cohort study	4
Machine learning-enhanced radiomics for predicting portal vein thrombectomy in liver transplantation	4
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection	4

Beyond chemotherapy in biliary tract cancer: a closer look at the updated long-term follow-up data of the TOPAZ-1 trial	4
Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?	4
The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications	4
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guide	4
Liver venous deprivation (LVD) before extended hepatectomy: a French multicentric retrospective cohort	4
A journey of a thousand miles begins with one small step	4
Hepatic metastases in ovarian cancer	4
Surgical techniques and tumor dissemination: a critical review of the CETUPANC trial on the superior mesenteric artery vs. no-touch approaches	4
Optimizing venous outflow reconstruction for V5 & V8 in right-lobe living-donor liver transplantation: “half-circumferential anastomosis” using autologous vein grafts	4
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation	4
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation	4
Biliary sphincterotomy for sphincter of Oddi disorder: is sphincterotomy cutting it?	4
Portal hypertensive biliopathy secondary to Abernethy malformation mimicking a hepatic hilum mass	4
Short- and long-term outcomes and cost-effectiveness of robotic-assisted versus laparoscopic liver resection for Barcelona Clinic Liver Cancer (BCLC) 0/A hepatocellular carcinoma: a multicenter propen	4
The difficulty of medical decision-making: should patients be involved?	4
Exocrine pancreatic insufficiency: more compromise than precision	4
Robotic pancreaticoduodenectomy after the learning curve—a new hope	4
Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer—the more the better?	4
The burden and forecasts for metabolic dysfunction-associated fatty liver disease among adolescents and young adults in the Arab region	3
Incomplete ablation vs. complete ablation for solitary hepatocellular carcinoma ≤5 cm: the 10-year survival analysis	3
Alternatives to left lateral sector in paediatric liver transplantation—a systematic review on monosegmental and reduced grafts	3
Modified T category for early-staged intrahepatic cholangiocarcinoma: inclusion of perineural invasion	3
Application of liver transplant techniques in complex liver surgery: modified techniques and preliminary results of complex liver resection using in-situ hypothermic portal perfusion without venovenou	3
Advances and controversies in the management of acute cholecystitis in high-risk, critically ill, and unfit-for-surgery patients: the Italian Society of Emergency Surgery and Trauma guidelines	3
From algorithms to adaptive frameworks: from square to circle in hepatocellular carcinoma management	3
Utility of liver resection for breast cancer liver metastases, time for action	3
Novel application of Yttrium-90 microsphere selective internal radiation therapy in hepatic metastases of primary fallopian tube carcinoma	3
Modern surgical approach to hepatocellular carcinoma	3
Quest for an accurate and reproducible prognostic biomarker of severe acute pancreatitis: have we finally found it?	3
Is immunotherapy-related liver injury more common in patients with hepatocellular carcinoma than in other advanced solid tumors?	3
Significant portal hypertension: porto-sinusoidal vascular disease associated with atypical Adams-Oliver syndrome	3
Inhibition of ferroptosis by propofol injectable emulsion protects hepatocytes against ischemia/reperfusion injury	3
Advancing risk stratification in intermediate-stage hepatocellular carcinoma undergoing transarterial chemoembolization: the promise of the NTAA model	3
Torsion of accessory liver lobe	3
Claude Bernard’s concept of sugar metabolism in the liver	3
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights	3
Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?	3
Anatomical study of the paracaval branch of the caudate lobe: implications of paracaval portion-preserving right hepatectomy for donors with marginal remnant liver volume	3
Liver anatomy by Francis Glisson	3
First reported post-transplant lymphoproliferative disorder after combined heart-liver transplantation	3
Time to say goodbye: from Barcelona to Milan and the modern management of hepatocellular carcinoma	3
Choledochoscopic photodynamic therapy combined with biliary stent implantation for the treatment of unresectable hilar cholangiocarcinoma	3
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy	3
Assessing the financial and equity implications of the 2020 liver allocation policy change	3
Definition, risk factors, and outcomes of early and late recurrence after curative resection for intrahepatic cholangiocarcinoma	3
In memoriam of Prof. Joseph Wan-yee Lau—our distinguished senior editorial board member	3
Effects of exercise and nutrition in improving sarcopenia in liver cirrhosis patients: a systematic review and meta-analysis	3
Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies	3
Advances in minimally invasive liver surgery: comparing robotic and laparoscopic approaches	3
The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease	3
Giant accessory hepatic lobe accompanied by inflammatory pseudotumor	3
“PUMC’s Three Treasures”: can their glory remain?	3
Guidelines towards comprehensive care in acute pancreatitis	3
Body mass index and ampulla of Vater cancer incidence and survival: a cohort study of 1.7 million Norwegians	3
The gut-liver axis: connecting carotenoids to non-alcoholic fatty liver disease prevention—a promising pathway for future research	3
Surgical treatment strategies for multifocal hepatocellular carcinomas	3
Impact of adjuvant therapy on survival outcomes in resected gallbladder cancer: a systematic review and meta-analysis	3
Pancreatic cancer screening in high-risk individuals with genetic susceptibility	3
Specific metabolic impairments indicate loss of sustained liver improvements in metabolic dysfunction-associated steatotic liver disease treatment	3
High risk of thrombosis recurrence in people with idiopathic or only locally caused non-cirrhotic splanchnic vein thrombosis: it is time for guidelines’ revision	3
Independent risk factors for clinically relevant postoperative pancreatic fistula after robotic pancreatoduodenectomy: the protective role of the modified Blumgart pancreatojejunostomy in a single sur	3
Balancing efficacy and tolerability in metastatic pancreatic cancer: lessons from the ALPACA trial	2
Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future	2
Where is the future of xenotransplantation headed?	2
Liver resection, and technical advances to mitigate post-hepatectomy liver failure	2
Revisiting the two-stage hepatectomy and hepatic arterial infusion chemotherapy for colorectal liver metastases: insights and long-term outcomes from a large cohort	2
The promise of precision medicine: how biomarkers are shaping the future of cholangiocarcinoma treatment	2
Clinical feasibility of modified extended left hemihepatectomy in advanced perihilar cholangiocarcinoma	2
Hepatocellular carcinoma in non-alcoholic fatty liver disease from a clinical and public health perspective	2
A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study	2
Cystic liver lesions: from diagnosis to recognition of complications and when to treat	2
Hepatoid adenocarcinoma of the rectal	2
Role of non-invasive tests in the management of resectable hepatocellular carcinoma: future directions	2
Evaluating liver resection outcomes post Y90 TARE with personalized dosimetry in intermediate or advanced hepatocellular carcinoma: a focus on surgical and biliary complications	2
Right or left hepatectomy: a continuing question in the era of pure laparoscopic donor hepatectomy	2
Breast cancer liver metastasis: time to resection and criteria	2
Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis	2
Hypovolemic phlebotomy and low central venous pressure: a paradigm shift in liver surgery?	2
Advancing prognostic models in salvage liver transplantation	2
Continuation of first-line therapy with progression-directed local therapy: a potential 1.5-line strategy bridging the gap between first- and second-line systemic therapy in oligoprogressive hepatocel	2
Short- and long-term outcomes of laparoscopic versus open resection of perihilar cholangiocarcinoma: a propensity score-based analysis	2
β-cryptoxanthin and fatty liver disease: new insights	2
Radiofrequency ablation for colorectal liver metastases: an evolving alternative or complement to resection?	2
Tract hemostasis using radiofrequency ablation for hepatic arterial bleeding after percutaneous transhepatic portal embolization	2
Stereotactic body radiation therapy and radiofrequency ablation in patients with hepatocellular carcinoma: not a rival but a partner for the cure	2
Improving outcomes of patients with severe respiratory and circulatory failure following living donor liver transplantation: efficacy of extracorporeal membrane oxygenation	2
Comparable results of surgical versus non-surgical management for patients with malignant bowel obstruction—a lesson from S1316 study	2
East meets West: what opportunities arise in comparing international guidelines for management of cirrhosis?	2
A rare case of giant paraganglioma in the first porta hepatis area associated with neurofibromatosis type 1	2
Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries	2
Pancreatic exocrine insufficiency guidelines: more questions than answers!	2
Based on the results of a large retrospective study comparing laparoscopic liver surgery and robotic liver surgery, is it time for the next step in robotic liver resection?	2
Rare case of leiomyomatosis peritonealis disseminata with hepatic involvement	2
Long-term normothermic machine perfusion of fatty livers: towards transplanting untransplantable livers?	2
James Hogarth Pringle and his time-honored maneuver	2